204 related articles for article (PubMed ID: 28832983)
1. Comparison of recommendations for screening mammography using CISNET models.
Arleo EK; Hendrick RE; Helvie MA; Sickles EA
Cancer; 2017 Oct; 123(19):3673-3680. PubMed ID: 28832983
[TBL] [Abstract][Full Text] [Related]
2. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates.
Monticciolo DL; Hendrick RE; Helvie MA
Radiology; 2024 Feb; 310(2):e232658. PubMed ID: 38376405
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of modelling mammography screening strategies.
Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
[TBL] [Abstract][Full Text] [Related]
6. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Oeffinger KC; Fontham ET; Etzioni R; Herzig A; Michaelson JS; Shih YC; Walter LC; Church TR; Flowers CR; LaMonte SJ; Wolf AM; DeSantis C; Lortet-Tieulent J; Andrews K; Manassaram-Baptiste D; Saslow D; Smith RA; Brawley OW; Wender R;
JAMA; 2015 Oct; 314(15):1599-614. PubMed ID: 26501536
[TBL] [Abstract][Full Text] [Related]
8. Estimated Mortality of Breast Cancer Patients Based on Stage at Diagnosis and National Screening Guideline Categorization.
Patel SB
J Am Coll Radiol; 2018 Sep; 15(9):1206-1213. PubMed ID: 29793836
[TBL] [Abstract][Full Text] [Related]
9. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
10. Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.
Alagoz O; Hajjar A; Chootipongchaivat S; van Ravesteyn NT; Yeh JM; Ergun MA; de Koning HJ; Chicoine B; Martin B
J Gen Intern Med; 2019 Nov; 34(11):2374-2381. PubMed ID: 31385214
[TBL] [Abstract][Full Text] [Related]
11. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
[TBL] [Abstract][Full Text] [Related]
12. Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old.
Hendrick RE; Helvie MA; Hardesty LA
AJR Am J Roentgenol; 2014 Dec; 203(6):1379-81. PubMed ID: 25415718
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP; Geuzinge HA; Stout NK; Alagoz O; Hampton J; Kerlikowske K; de Koning HJ; Miglioretti DL; van Ravesteyn NT; Schechter C; Sprague BL; Tosteson ANA; Trentham-Dietz A; Weaver D; Yaffe MJ; Yeh JM; Couch FJ; Hu C; Kraft P; Polley EC; Mandelblatt JS; Kurian AW; Robson ME;
JAMA Oncol; 2022 Apr; 8(4):587-596. PubMed ID: 35175286
[TBL] [Abstract][Full Text] [Related]
14. United States Preventive Services Task Force screening mammography recommendations: science ignored.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
[TBL] [Abstract][Full Text] [Related]
15. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
Stout NK; Lee SJ; Schechter CB; Kerlikowske K; Alagoz O; Berry D; Buist DS; Cevik M; Chisholm G; de Koning HJ; Huang H; Hubbard RA; Miglioretti DL; Munsell MF; Trentham-Dietz A; van Ravesteyn NT; Tosteson AN; Mandelblatt JS
J Natl Cancer Inst; 2014 Jun; 106(6):dju092. PubMed ID: 24872543
[TBL] [Abstract][Full Text] [Related]
16. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
[TBL] [Abstract][Full Text] [Related]
17. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
18. Identifying Equitable Screening Mammography Strategies for Black Women in the United States Using Simulation Modeling.
Chapman CH; Schechter CB; Cadham CJ; Trentham-Dietz A; Gangnon RE; Jagsi R; Mandelblatt JS
Ann Intern Med; 2021 Dec; 174(12):1637-1646. PubMed ID: 34662151
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of mammographic screening strategies.
Lindfors KK; Rosenquist CJ
JAMA; 1995 Sep; 274(11):881-4. PubMed ID: 7674501
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]